UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial

Haematologica (Roma), 2013-07, Vol.98 (7), p.1067-1072

2013

Link zum Volltext

Verfügbarkeit prüfen

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma

Blood cancer journal (New York), 2021-06, Vol.11 (6), p.116-116, Article 116

2021

Link zum Volltext

Verfügbarkeit prüfen

“To wheeze or not to wheeze”: That is not the question—the sequel

Journal of allergy and clinical immunology, 2012-08, Vol.130 (2), p.531-532

2012

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma

International journal of hematology, 2012-08, Vol.96 (2), p.254-262

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

BMC endocrine disorders, 2008-10, Vol.8 (1), p.14-14, Article 14

2008

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry

EJHaem, 2020-07, Vol.1 (1), p.188-198

2020

Link zum Volltext

Verfügbarkeit prüfen

Predicting an asthma exacerbation in children 2 to 5 years of age

Annals of allergy, asthma, & immunology, 2008-12, Vol.101 (6), p.626-630

2008

Link zum Volltext

Verfügbarkeit prüfen

Seasonal patterns in health care use and pharmaceutical claims for asthma prescriptions for preschool- and school-aged children

Annals of allergy, asthma, & immunology, 2009-03, Vol.102 (3), p.198-204

2009

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine in Lower‐Risk Myelodysplastic Syndromes: A Meta‐Analysis of Data from Prospective Studies

The oncologist (Dayton, Ohio), 2018-02, Vol.23 (2), p.159-170

2018

Link zum Volltext

Verfügbarkeit prüfen

Real‐world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres

British journal of haematology, 2016-12, Vol.175 (5), p.892-903

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

Annals of hematology, 2018-12, Vol.97 (12), p.2425-2436

2018

Link zum Volltext

Verfügbarkeit prüfen

Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome

Blood, 2012-10, Vol.120 (17), p.3419-3424

2012

Link zum Volltext

Verfügbarkeit prüfen

Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States

BMJ open, 2018-07, Vol.8 (7), p.e019955-e019955

2018

Link zum Volltext

Verfügbarkeit prüfen

Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the AVIDA® registry

Leukemia & lymphoma, 2015-04, Vol.56 (4), p.887-895

2015

Link zum Volltext

Verfügbarkeit prüfen

Perceptions of Disease State, Treatment Outcomes, and Prognosis Among Patients with Myelodysplastic Syndromes: Results from an Internet‐Based Survey

The oncologist (Dayton, Ohio), 2011-06, Vol.16 (6), p.904-911

2011

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry

Clinical lymphoma, myeloma and leukemia, 2018-02, Vol.18 (2), p.114-124.e2

2018

Link zum Volltext

Verfügbarkeit prüfen

Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States

BMC cancer, 2017-03, Vol.17 (1), p.198-198, Article 198

2017

Link zum Volltext

Verfügbarkeit prüfen

Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect® CLL cohort study

Leukemia & lymphoma, 2018-10, Vol.59 (10), p.2327-2335

2018

Link zum Volltext

Verfügbarkeit prüfen

Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative

Therapeutic innovation & regulatory science, 2021-01, Vol.55 (1), p.6-18

2021

Link zum Volltext

Verfügbarkeit prüfen

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)

Blood cancer journal (New York), 2018-09, Vol.8 (10), p.90-4, Article 90

2018

Link zum Volltext

Verfügbarkeit prüfen

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study

BMC cancer, 2016-08, Vol.16 (1), p.652-652, Article 652

2016

Link zum Volltext

Verfügbarkeit prüfen

Real‐world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower‐risk myelodysplastic syndromes

International journal of laboratory hematology, 2021-06, Vol.43 (3), p.426-432

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia

Supportive care in cancer, 2013-10, Vol.21 (10), p.2853-2860

2013

Link zum Volltext

Verfügbarkeit prüfen

The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites

Blood advances, 2020-04, Vol.4 (7), p.1407-1418

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(101)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(28)
Female
(21)
Male
(20)
Middle Aged
(17)
Aged
(16)
Hematology
(15)
Adult
(14)
Aged, 80 And Over
(13)
Oncology
(13)
Prospective Studies
(10)
Quality Of Life
(9)
Treatment Outcome
(9)
Prognosis
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Registries
(7)
Biological And Medical Sciences
(6)
Clinical Trials
(6)
Medical Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma

“To wheeze or not to wheeze”: That is not the question—the sequel

Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myeloma

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry

Predicting an asthma exacerbation in children 2 to 5 years of age

Seasonal patterns in health care use and pharmaceutical claims for asthma prescriptions for preschool- and school-aged children

Azacitidine in Lower‐Risk Myelodysplastic Syndromes: A Meta‐Analysis of Data from Prospective Studies

Real‐world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome

Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States

Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the AVIDA® registry

Perceptions of Disease State, Treatment Outcomes, and Prognosis Among Patients with Myelodysplastic Syndromes: Results from an Internet‐Based Survey

Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry

Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States

Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect® CLL cohort study

Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study

Real‐world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower‐risk myelodysplastic syndromes

Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia

The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites

Suchergebnisse filtern